Johnson & Johnson ( JNJ ) will begin trading ex-dividend on November 20, 2015. A cash dividend payment of $0.75 per share is scheduled to be paid on December 08, 2015. Shareholders who purchased JNJ prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 3rd quarter that JNJ has paid the same dividend. At the current stock price of $102.67, the dividend yield is 2.92%.
The previous trading day's last sale of JNJ was $102.67, representing a -5.8% decrease from the 52 week high of $108.99 and a 25.53% increase over the 52 week low of $81.79.
JNJ is a part of the Health Care sector, which includes companies such as Novartis AG ( NVS ) and Pfizer, Inc. ( PFE ). JNJ's current earnings per share, an indicator of a company's profitability, is $5.23. Zacks Investment Research reports JNJ's forecasted earnings growth in 2015 as 3.55%, compared to an industry average of 5.2%.
Interested in gaining exposure to JNJ through an Exchange Traded Fund [ETF]?
The following ETF(s) have JNJ as a top-10 holding:
- iShares U.S. Healthcare ETF ( IYH )
- Vanguard Health Care ETF - DNQ ( VHT )
- Market Vectors Pharmaceutical ETF ( PPH )
- iShares U.S. Pharmaceutical ETF ( IHE )
- SPDR Select Sector Fund - Health Care ( XLV ).
The top-performing ETF of this group is XLV with an decrease of -2.71% over the last 100 days. IYH has the highest percent weighting of JNJ at 9.68%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.